Clinical Outcomes After Ustekinumab Biosimilar Switching in Crohn’s Disease: The USBIOS–Italian Group for the Study of Inflammatory Bowel Disease Study

Davide Giuseppe Ribaldone, Elisa Tribocco, Franco Scaldaferri, Marco Murgiano, Simone Parello, Federica Di Vincenzo, Angelo Del Gaudio, Pierluigi Puca, Daniele Napolitano, Alfredo Papa, Loris Riccardo Lopetuso, Lucrezia Laterza, Cristina Bezzio, Alessandro Armuzzi, Valeria Farinola, Edoardo Vincenzo Savarino, Fabiana Zingone, Brigida Barberio, Luisa Bertin, Alessia Todeschini, Angela Variola, Anna Maria Carvalhas Gabrielli, Francesca Ferretti, Rosanna Cannatelli, Antonietta Gerarda Gravina, Raffaele Pellegrino, Anna Viola, Clara De Francesco, Fabrizio Bossa, Luca Pastorelli, Carla Felice, Gabriele Dragoni, Daniele Canova, Linda Cingolani, Rocco Spagnuolo, Maria Maddalena Terpin, Alessandra Zilli, Ambra Magiotta, Francesco Segatta, Simone Saibeni, Ana Juverdeanu, Marta Vernero, Gian Paolo Caviglia

Open source

DOI: 10.1016/j.cgh.2026.08.014
Published: 2026-08
Container: Clinical Gastroenterology and Hepatology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.cgh.2026.08.014,
  title = {Clinical Outcomes After Ustekinumab Biosimilar Switching in Crohn’s Disease: The USBIOS–Italian Group for the Study of Inflammatory Bowel Disease Study},
  author = {Davide Giuseppe Ribaldone and Elisa Tribocco and Franco Scaldaferri and Marco Murgiano and Simone Parello and Federica Di Vincenzo and Angelo Del Gaudio and Pierluigi Puca and Daniele Napolitano and Alfredo Papa and Loris Riccardo Lopetuso and Lucrezia Laterza and Cristina Bezzio and Alessandro Armuzzi and Valeria Farinola and Edoardo Vincenzo Savarino and Fabiana Zingone and Brigida Barberio and Luisa Bertin and Alessia Todeschini and Angela Variola and Anna Maria Carvalhas Gabrielli and Francesca Ferretti and Rosanna Cannatelli and Antonietta Gerarda Gravina and Raffaele Pellegrino and Anna Viola and Clara De Francesco and Fabrizio Bossa and Luca Pastorelli and Carla Felice and Gabriele Dragoni and Daniele Canova and Linda Cingolani and Rocco Spagnuolo and Maria Maddalena Terpin and Alessandra Zilli and Ambra Magiotta and Francesco Segatta and Simone Saibeni and Ana Juverdeanu and Marta Vernero and Gian Paolo Caviglia},
  year = {2026},
  journal = {Clinical Gastroenterology and Hepatology},
  doi = {10.1016/j.cgh.2026.08.014},
  url = {https://doi.org/10.1016/j.cgh.2026.08.014}
}

RIS

TY  - JOUR
TI  - Clinical Outcomes After Ustekinumab Biosimilar Switching in Crohn’s Disease: The USBIOS–Italian Group for the Study of Inflammatory Bowel Disease Study
AU  - Davide Giuseppe Ribaldone
AU  - Elisa Tribocco
AU  - Franco Scaldaferri
AU  - Marco Murgiano
AU  - Simone Parello
AU  - Federica Di Vincenzo
AU  - Angelo Del Gaudio
AU  - Pierluigi Puca
AU  - Daniele Napolitano
AU  - Alfredo Papa
AU  - Loris Riccardo Lopetuso
AU  - Lucrezia Laterza
AU  - Cristina Bezzio
AU  - Alessandro Armuzzi
AU  - Valeria Farinola
AU  - Edoardo Vincenzo Savarino
AU  - Fabiana Zingone
AU  - Brigida Barberio
AU  - Luisa Bertin
AU  - Alessia Todeschini
AU  - Angela Variola
AU  - Anna Maria Carvalhas Gabrielli
AU  - Francesca Ferretti
AU  - Rosanna Cannatelli
AU  - Antonietta Gerarda Gravina
AU  - Raffaele Pellegrino
AU  - Anna Viola
AU  - Clara De Francesco
AU  - Fabrizio Bossa
AU  - Luca Pastorelli
AU  - Carla Felice
AU  - Gabriele Dragoni
AU  - Daniele Canova
AU  - Linda Cingolani
AU  - Rocco Spagnuolo
AU  - Maria Maddalena Terpin
AU  - Alessandra Zilli
AU  - Ambra Magiotta
AU  - Francesco Segatta
AU  - Simone Saibeni
AU  - Ana Juverdeanu
AU  - Marta Vernero
AU  - Gian Paolo Caviglia
PY  - 2026
JO  - Clinical Gastroenterology and Hepatology
DO  - 10.1016/j.cgh.2026.08.014
UR  - https://doi.org/10.1016/j.cgh.2026.08.014
ER  -

APA

Ribaldone, D. G., Tribocco, E., Scaldaferri, F., Murgiano, M., Parello, S., Vincenzo, F. D., Gaudio, A. D., Puca, P., Napolitano, D., Papa, A., Lopetuso, L. R., Laterza, L., Bezzio, C., Armuzzi, A., Farinola, V., Savarino, E. V., Zingone, F., Barberio, B., Bertin, L., Todeschini, A., Variola, A., Gabrielli, A. M. C., Ferretti, F., Cannatelli, R., Gravina, A. G., Pellegrino, R., Viola, A., Francesco, C. D., Bossa, F., Pastorelli, L., Felice, C., Dragoni, G., Canova, D., Cingolani, L., Spagnuolo, R., Terpin, M. M., Zilli, A., Magiotta, A., Segatta, F., Saibeni, S., Juverdeanu, A., Vernero, M., & Caviglia, G. P. (2026). Clinical Outcomes After Ustekinumab Biosimilar Switching in Crohn’s Disease: The USBIOS–Italian Group for the Study of Inflammatory Bowel Disease Study. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2026.08.014

Source records

crossref · retrieved 2026-09-27T04:26:19.085Z